Alvotech is trading at ISK 754, up +10.56%, after FDA approval allowed a second Reykjavik suite to make SIMLANDI drug substance for U.S. supply. - On October 5

Alvotech is trading at ISK 754, up +10.56%, after FDA approval allowed a second Reykjavik suite to make SIMLANDI drug substance for U.S. supply. - On October 5, 2026, the company said the approval effectively doubles available manufacturing capacity and confirms resolution of inspection-related mat…